Cargando…

Safety, Feasibility and Technical Considerations from a Prospective, Observational Study—CIREL: Irinotecan-TACE for CRLM in 152 Patients

CIREL, a prospective, Europe-wide, observational study aimed to assess the real-world feasibility and tolerability of irinotecan-based transarterial chemoembolization (LP-irinotecan TACE) for unresectable colorectal cancer liver metastases with regard to the treatment plan and adverse events (AEs)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Helmberger, Thomas, Lucatelli, Pierleone, Pereira, Philippe L., Gjoreski, Aleksandar, Jovanoska, Ivona, Bansaghi, Zoltan, Spiliopoulos, Stavros, Carchesio, Francesca, Arnold, Dirk, Baierl, Andreas, Zeka, Bleranda, Kaufmann, Nathalie C., Taieb, Julien, Iezzi, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604674/ https://www.ncbi.nlm.nih.gov/pubmed/36294499 http://dx.doi.org/10.3390/jcm11206178

Ejemplares similares

The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis
por: Pereira, Philippe L., et al.
Publicado: (2020)

Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

DEB-TACE with irinotecan versus C-TACE for unresectable intrahepatic cholangiocarcinoma: a prospective clinical study
por: Wang, Junxiao, et al.
Publicado: (2023)

Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results
por: Lucatelli, Pierleone, et al.
Publicado: (2019)

Müller cells and retinal axons can be primary targets in experimental neuromyelitis optica spectrum disorder
por: Zeka, Bleranda, et al.
Publicado: (2017)

Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience
por: Nassabein, Rami, et al.
Publicado: (2021)

Study: International Multicentric Minimally Invasive Liver Resection for Colorectal Liver Metastases (SIMMILR-CRLM)
por: Gumbs, Andrew A., et al.
Publicado: (2022)

Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients—A Retrospective Observational Study
por: Brozzetti, Stefania, et al.
Publicado: (2022)

No.253 Lymph Nodes Metastasis in Left-Sided Colorectal Cancer Liver Metastasis (CRLM) Patients: Incidence and Prognosis
por: Chang, Jiang, et al.
Publicado: (2022)

Locoregional therapy response in patients with hepatocellular cancer waiting for liver transplantation: Only selection or biological effect?
por: Lai, Quirino, et al.
Publicado: (2018)

Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin
por: Siriwardana, Pulathis N., et al.
Publicado: (2016)

MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts
por: van Tilborg, Aukje A. J. M., et al.
Publicado: (2016)

Liver transplantation for unresectable colorectal liver metastases (CRLM) using extended criteria donor (ECD) grafts: proceed with caution
por: Nadalin, Silvio
Publicado: (2023)

The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases
por: Vogl, Thomas J., et al.
Publicado: (2022)

Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report
por: Martin, Robert CG, et al.
Publicado: (2009)

TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
por: Lu, Haohao, et al.
Publicado: (2023)

Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study
por: Kolligs, Frank, et al.
Publicado: (2022)

Individualized Selection Criteria Based on Tumor Burden in Future Remnant Liver for Staged Hepatectomy of Advanced CRLM: Conventional TSH or ALPPS
por: Chan, Kun-Ming, et al.
Publicado: (2022)

LncRNA CRLM1 inhibits apoptosis and promotes metastasis through transcriptional regulation cooperated with hnRNPK in colorectal cancer
por: Wang, Zhe, et al.
Publicado: (2022)

Transarterial Chemoembolization of Child-A hepatocellular carcinoma: Drug-eluting bead TACE (DEB TACE) vs. TACE with Cisplatin/Lipiodol (cTACE)
por: Wiggermann, Philipp, et al.
Publicado: (2011)

Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study
por: Maleux, Geert, et al.
Publicado: (2023)

Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study
por: Tanaka, Toshihiro, et al.
Publicado: (2019)

Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE?
por: Ge, Naijian, et al.
Publicado: (2023)

Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord
por: Oji, Satoru, et al.
Publicado: (2016)

Chinese expert consensus on technical recommendations for the standard operation of drug-eluting beads for transvascular embolization
por: Shao, Guoliang, et al.
Publicado: (2021)

Microballoon Interventions for Liver Tumors: Review of Literature and Future Perspectives
por: Lucatelli, Pierleone, et al.
Publicado: (2022)

Splenic Artery Pseudoaneurysms: The Role of ce-CT for Diagnosis and Treatment Planning
por: Corvino, Fabio, et al.
Publicado: (2022)

Bleeding in COVID Patients: What We Have Understood So Far
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
por: Kim, Jung Hee, et al.
Publicado: (2017)

Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
por: Fan, Wenzhe, et al.
Publicado: (2021)

TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial
por: Féray, Cyrille, et al.
Publicado: (2023)

European Multicenter Study on Degradable Starch Microsphere TACE: The Digestible Way to Conquer HCC in Patients with High Tumor Burden
por: Ludwig, Johannes M., et al.
Publicado: (2021)

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis
por: Scartozzi, Mario, et al.
Publicado: (2010)

IAU Colloquium 152
Publicado: (1995)

Possible use of Digital Variance Angiography in Liver Transarterial Chemoembolization: A Retrospective Observational Study
por: Lucatelli, Pierleone, et al.
Publicado: (2023)

Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression
por: Zou, Xinhua, et al.
Publicado: (2021)

Efficacy and Safety of TACE Combined with Regorafenib versus TACE in the Third-Line Treatment of Colorectal Liver Metastases
por: Lu, Haohao, et al.
Publicado: (2022)

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD
por: Zeka, Bleranda, et al.
Publicado: (2016)

Drug-eluting bead transarterial chemoembolization (TACE) vs conventional TACE in treating hepatocellular carcinoma patients with multiple conventional TACE treatments history: A comparison of efficacy and safety
por: Li, Hui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e2jkce60d8h6ss0889ntksifrg